Humacyte, Inc. (HUMA) Reports Q2 2026 Financial Results (press release)

What Happened Humacyte, Inc. (HUMA) filed a Form 8-K on August 12, 2026 to announce and furnish a press release reporting its results of operations and financial condition for the fiscal second quarter ended June 30, 2026. The press release is attached to the 8-K as Exhibit 99.1 and is the primary source of the company’s reported quarterly results.

Key Details

• Filing date: August 12, 2026; quarter ended: June 30, 2026.
• The company furnished (not filed) a press release with its Q2 2026 financial results as Exhibit 99.1.
• The 8-K states the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
• Investors should consult the press release (Exhibit 99.1) for the specific financial figures and metrics announced.

Why It Matters This filing signals that Humacyte has publicly released its quarterly earnings and operational results for Q2 2026; those details (revenue, net loss/profit, cash position, guidance or operational updates) will be in the attached press release and are material for evaluating the company’s near-term performance. Because the press release is furnished rather than “filed,” investors should also review Humacyte’s upcoming periodic reports (e.g., Form 10-Q) for the audited/regularized financial statements and management discussion and analysis.